Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Febrile Neutropenia 6Neutropenia 5Neoplasms 4Infections 4Fever 4Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Hematologic Neoplasms 2Waldenstrom Macroglobulinemia 1Urinary Tract Infections 1Stomach Neoplasms 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Recurrence 1Pulmonary Arterial Hypertension 1Pseudomonas Infections 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pancreatic Neoplasms 1

Interventions

ceftolozane, tazobactam drug combination 1ceftobiprole medocaril 1Vancomycin 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pseudomonas Infections × Vancomycin × Clear all
NCT00529282 2012-08-01

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Basilea Pharmaceutica

Phase 3 Terminated
2 enrolled 4 charts

Fever, Neutropenia, Pseudomonas Infections, Gram-Positive Bacterial Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡